MANETTI, MIRKO
 Distribuzione geografica
Continente #
NA - Nord America 8.463
EU - Europa 4.706
AS - Asia 1.121
AF - Africa 16
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 3
OC - Oceania 2
Totale 14.315
Nazione #
US - Stati Uniti d'America 8.426
PL - Polonia 1.644
IE - Irlanda 846
IT - Italia 680
SE - Svezia 632
RU - Federazione Russa 366
HK - Hong Kong 354
CN - Cina 333
SG - Singapore 177
FI - Finlandia 150
DE - Germania 95
JO - Giordania 93
GB - Regno Unito 89
VN - Vietnam 63
UA - Ucraina 62
CH - Svizzera 34
IN - India 34
CA - Canada 31
TR - Turchia 29
ES - Italia 27
KR - Corea 18
BE - Belgio 16
FR - Francia 13
UG - Uganda 11
NL - Olanda 10
LV - Lettonia 8
MK - Macedonia 8
PH - Filippine 8
JP - Giappone 6
MX - Messico 6
DK - Danimarca 5
EU - Europa 4
LU - Lussemburgo 4
AT - Austria 3
CZ - Repubblica Ceca 3
GR - Grecia 3
RO - Romania 3
BR - Brasile 2
EG - Egitto 2
NO - Norvegia 2
PK - Pakistan 2
RS - Serbia 2
SC - Seychelles 2
AU - Australia 1
BA - Bosnia-Erzegovina 1
CL - Cile 1
IR - Iran 1
LA - Repubblica Popolare Democratica del Laos 1
NZ - Nuova Zelanda 1
SA - Arabia Saudita 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 14.315
Città #
Warsaw 1.642
Fairfield 1.508
Dublin 832
Ashburn 793
Chandler 732
Woodbridge 685
Cambridge 604
Seattle 603
Houston 559
Wilmington 460
Ann Arbor 225
Princeton 222
Lawrence 213
Altamura 206
Florence 182
Hong Kong 170
Beijing 157
Medford 138
Singapore 121
Jacksonville 118
Boston 108
Boardman 106
San Diego 87
Shanghai 65
Moscow 58
Falls Church 51
Buffalo 46
New York 45
Dong Ket 40
Norwalk 40
Hillsboro 29
Kent 27
Barcelona 24
London 24
Toronto 24
Los Angeles 23
Andover 22
Milan 22
Pune 21
Izmir 20
Bern 19
Fiesole 19
West Jordan 18
Castelliri 16
Dearborn 14
Seoul 14
Redwood City 13
Brussels 11
Lappeenranta 11
Lucca 11
Salerno 11
Phoenix 10
Nanjing 9
Kampala 8
Riga 8
Sesto Fiorentino 8
Rome 7
Helsinki 6
Kunming 6
Shenzhen 6
Bozeman 5
Guangzhou 5
Kilburn 5
Napoli 5
Padova 5
Redmond 5
Tappahannock 5
Caserta 4
Chicago 4
Genoa 4
Hefei 4
Kochi 4
Milazzo 4
Prato 4
Skopje 4
Washington 4
Wuhan 4
Amman 3
Ankara 3
Campi Bisenzio 3
Cascina 3
Catania 3
Düsseldorf 3
Frankfurt Am Main 3
Guiyang 3
Gustavo Adolfo Madero 3
Hanoi 3
L'aquila 3
Laurel 3
Legnano 3
Louvain-la-Neuve 3
Monterrey 3
Munich 3
North Bergen 3
Pisa 3
Vienna 3
Wuxi 3
Zibo 3
Acton 2
Arnsberg 2
Totale 11.419
Nome #
Systemic Sclerosis Sera Impair Angiogenic Performance of Dermal Microvascular Endothelial Cells: Therapeutic Implications of Cyclophosphamide 239
Plexin-D1/Semaphorin 3E pathway may contribute to dysregulation of vascular tone control and defective angiogenesis in systemic sclerosis 221
Altered Immunoregulation in Rheumatoid Arthritis: The Role of Regulatory T Cells and Proinflammatory Th17 Cells and Therapeutic Implications 215
Angiogenic T cell expansion correlates with severity of peripheral vascular damage in systemic sclerosis 210
The crowded crossroad to angiogenesis in systemic sclerosis: where is the key to the problem? 210
Systemic sclerosis sera affect fibrillin-1 deposition by dermal blood microvascular endothelial cells: therapeutic implications of cyclophosphamide 195
Anti-Fas IgM monoclonal antibody (anti-Fas mAb) effect on haemophilic arthropathy (HA) synoviocytes 194
Decreased expression of the endothelial cell-derived factor EGFL7 in systemic sclerosis: potential contribution to impaired angiogenesis and vasculogenesis 193
Multimodal imaging in the diagnosis and evaluation of intestinal malrotations in adults: a case report 179
The "myth" of loss of angiogenesis in systemic sclerosis: A pivotal early pathogenetic process or just a late unavoidable event? 163
Clinical, instrumental, serological and histological findings suggest that hemophilia B may be less severe than hemophilia A 148
Psychological well-being and quality of life in visually impaired baseball players: An Italian national survey 141
Pathophysiology of Hemophilic Arthropathy 130
Longitudinal assessment of the impact of adapted physical activity on upper limb disability and quality of life in breast cancer survivors from an Italian cohort 122
Role of a Structured Physical Activity Pathway in Improving Functional Disability, Pain and Quality of Life in a Case of Breast and Gynecological Cancer Survivorship 121
Proangiogenic effects of soluble α-Klotho on systemic sclerosis dermal microvascular endothelial cells 120
The -670G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis 119
A case of in vivo iontophoresis-assisted corneal collagen cross-linking for keratoconus: An immunohistochemical study 119
Decreased expression of neuropilin-1 as a novel key factor contributing to peripheral microvasculopathy and defective angiogenesis in systemic sclerosis 119
Systemic sclerosis-like histopathological features in the myocardium of uPAR-deficient mice 118
Vascular leaking, a pivotal and early pathogenetic event in systemic sclerosis: should the door be closed? 116
Reappraising the microscopic anatomy of human testis: identification of telocyte networks in the peritubular and intertubular stromal space 113
TNF-α/TNF-R System May Represent a Crucial Mediator of Proliferative Synovitis in Hemophilia A 113
Targeting anticoagulant protein S to improve hemostasis in hemophilia 113
Insulin-like growth factor binding protein 6 in rheumatoid arthritis: A possible novel chemotactic factor? 113
Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis 109
A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis 108
Agonistic anti-human Fas monoclonal antibody induces fibroblast-like synoviocyte apoptosis in haemophilic arthropathy: potential therapeutic implications 106
Differential expression of junctional adhesion molecules in different stages of systemic sclerosis 106
A case of mandible hypoplasia treated with autologous bone graft from mandibular symphysis: Expression of VEGF and receptors in bone regeneration. 105
Telocytes in normal and keratoconic human cornea: an immunohistochemical and transmission electron microscopy study 105
Telocytes are reduced during fibrotic remodelling of the colonic wall in ulcerative colitis 103
Morphological evidence for telocytes as stromal cells supporting satellite cell activation in eccentric contraction-induced skeletal muscle injury 102
Cardiac Telocyte-Derived Exosomes and Their Possible Implications in Cardiovascular Pathophysiology 102
Differential expression of stromal cell-derived factor 1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: Pathogenetic implications 101
Mechanisms in the loss of capillaries in systemic sclerosis: angiogenesis versus vasculogenesis 100
Severe fibrotic changes and altered expression of angiogenic factors in maternal scleroderma: placental findings. 99
Morphological evidence of telocytes in human synovium 97
Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro 97
Angiotensin II type 2 receptor (AT2R) as a novel modulator of inflammation in rheumatoid arthritis synovium 97
Systemic Sclerosis Serum Steers the Differentiation of Adipose-Derived Stem Cells Toward Profibrotic Myofibroblasts: Pathophysiologic Implications 96
A loss of telocytes accompanies fibrosis of multiple organs in systemic sclerosis 95
Telocytes constitute a widespread interstitial meshwork in the lamina propria and underlying striated muscle of human tongue 94
The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis 93
Variations of neuronal nitric oxide synthase in systemic sclerosis skin 92
Telocytes in minor salivary glands of primary Sjogren’s syndrome: association with the extent of inflammation and ectopic lymphoid neogenesis 92
Mechanisms of vascular disease 91
Neuropeptides activate TRPV1 in rheumatoid arthritis fibroblast-like synoviocytes and foster IL-6 and IL-8 production. 90
Mobilization of lymphatic endothelial precursor cells and lymphatic neovascularization in primary Sjögren's syndrome 90
Long-Term Benefits of Adapted Physical Activity on Upper Limb Performance and Quality of Life in Breast Cancer Survivors 88
Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage 88
Stiff skin syndrome: evidence for an inflammation-independent fibrosis? 86
Inactivation of urokinase-type plasminogen activator receptor (uPAR) gene induces dermal and pulmonary fibrosis and peripheral microvasculopathy in mice: a new model of experimental scleroderma? 86
Evidence for the prevention of enthesitis in HLA-B27/hβ(2)m transgenic rats treated with a monoclonal antibody against TNF-α. 85
Evidence for a Derangement of the Microvascular System in Patients with a Very Early Diagnosis of Systemic Sclerosis 85
Emerging biomarkers in systemic sclerosis 84
Evidence for progressive reduction and loss of telocytes in the dermal cellular network of systemic sclerosis 84
Enthesopathy and involvement of synovio-entheseal complex in systemic sclerosis: an ultrasound pilot study 84
A two-step immunomagnetic microbead-based method for the isolation of human primary skin telocytes/CD34+ stromal cells 83
Concomitant Spondyloarthritis and Tenosynovial Giant Cell Tumor in Pigmented Villonodular Synovitis Challenging Cases 82
Do new and old biomarkers of early undifferentiated arthritis correlate with Arthritis Impact Measurement Scales? 82
Increased circulating levels of interleukin-33 in systemic sclerosis correlate with early disease stage and microvascular involvement 81
Telocytes in human fetal skeletal muscle interstitium during early myogenesis 81
Blockade of CCL24 with a monoclonal antibody ameliorates experimental dermal and pulmonary fibrosis 81
Association between a stromal cell-derived factor 1 (SDF-1/CXCL12) gene polymorphism and microvascular disease in systemic sclerosis. 80
Progressive loss of lymphatic vessels in skin of patients with systemic sclerosis 80
Deciphering the alternatively activated (M2) phenotype of macrophages in scleroderma 80
Immunolocalization of VEGF/VEGFR system in human fetal vomeronasal organ during early development 80
Changes in the telocyte/CD34+ stromal cell and α-SMA+ myoid cell networks in human testicular seminoma 80
Blocking Protein S Improves Hemostasis in Hemophilia A and B 80
Occult spondyloarthritis in inflammatory bowel disease 79
Telocytes in chronic inflamatory and fibrotic diseases 79
Characterization and distribution of sialic acids in human testicular seminoma 79
Telocytes in Crohn's disease 78
Disease Activity Improvement in Rheumatoid Arthritis Treated with Tumor Necrosis Factor-α Inhibitors Correlates with Increased Soluble Fas Levels. 78
Impaired angiogenesis in systemic sclerosis: the emerging role of the antiangiogenic VEGF165b splice variant 77
The origin of the myofibroblast in fibroproliferative vasculopathy: does the endothelial cell steer the pathophysiology of systemic sclerosis? 77
Fli1 deficiency and beyond: a unique pathway linking peripheral vasculopathy and dermal fibrosis in systemic sclerosis 76
Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis 76
Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis 74
Glycolysis-derived acidic microenvironment as a driver of endothelial dysfunction in systemic sclerosis 74
A loss of telocytes accompanies fibrosis of multiple organs in systemic sclerosis 73
Association of a functional polymorphism in the matrix metalloproteinase-12 promoter region with systemic sclerosis in an Italian population 73
Vascular biomarkers and correlation with peripheral vasculopathy in systemic sclerosis 73
Slit2/Robo4 axis may contribute to endothelial cell dysfunction and angiogenesis disturbance in systemic sclerosis 73
Could autologous adipose-derived stromal vascular fraction turn out an unwanted source of profibrotic myofibroblasts in systemic sclerosis? 72
Self-reported active lifestyle behavior and upper limb disability in breast cancer survivors following a structured adapted physical activity intervention 71
Endothelial/lymphocyte activation leads to prominent CD4+ T cell infiltration in the gastric mucosa of patients with systemic sclerosis 71
Bone Marrow-Mesenchymal Stromal Cell Secretome as Conditioned Medium Relieves Experimental Skeletal Muscle Damage Induced by Ex Vivo Eccentric Contraction 71
Decreased circulating lymphatic endothelial progenitor cells in digital ulcer-complicated systemic sclerosis 70
Evidence for caveolin-1 as a new susceptibility gene regulating tissue fibrosis in systemic sclerosis 69
Increased plasma levels of the VEGF165b splice variant are associated with the severity of nailfold capillary loss in systemic sclerosis 69
Analysis of vascular gene expression in arthritic synovium by laser-mediated microdissection 69
Effects of a specific adapted upper limb exercise on lymphedema in breast cancer survivors: a pilot study 68
In search for the ideal anatomical composition of vascularised human skin equivalents for systemic sclerosis translational research: should we recruit the telocytes? 68
Telocytes and lymphatic endothelial cells: Two immunophenotypically distinct and spatially close cell entities 67
Telocyte implications in human pathology: An overview 67
A loss of telocytes accompanies fibrosis of multiple organs in systemic sclerosis 65
The contribution of mesenchymal transitions to the pathogenesis of systemic sclerosis 65
Domain 1 of the urokinase-type plasminogen activator receptor is required for its morphologic and functional, beta2 integrin-mediated connection with actin cytoskeleton in human microvascular endothelial cells: failure of association in systemic sclerosis endothelial cells 63
Totale 10.118
Categoria #
all - tutte 49.154
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.154


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.866 0 155 82 269 360 371 367 369 365 226 254 48
2020/20212.619 190 170 146 532 104 211 149 155 287 382 152 141
2021/20221.363 30 84 72 71 57 112 51 64 101 83 144 494
2022/20233.474 374 641 149 245 231 637 489 187 325 48 84 64
2023/20241.467 43 174 281 72 104 198 84 233 22 82 99 75
2024/2025546 381 165 0 0 0 0 0 0 0 0 0 0
Totale 14.859